Dietmann, Anne-Sophie
Kruse, Niels
Stork, Lidia
Gloth, Mareike
Brück, Wolfgang
Metz, Imke http://orcid.org/0000-0002-6571-7630
Funding for this research was provided by:
Novartis Pharma
Georg-August-Universität Göttingen
Article History
Received: 19 September 2022
Revised: 29 October 2022
Accepted: 31 October 2022
First Online: 13 November 2022
Declarations
:
: ASD, NK, LS, and MG have nothing to disclose. IM reports grants from Novartis Pharma GmbH, during the conduct of the study; personal fees from BiogenIdec, Bayer Healthcare, TEVA, Serono, Novartis Pharma GmbH, Genzyme, Roche, grants from BiogenIdec, Genzyme, outside the submitted work. WB has nothing to disclose related to this work.